TW282458B - - Google Patents
Info
- Publication number
- TW282458B TW282458B TW083101774A TW83101774A TW282458B TW 282458 B TW282458 B TW 282458B TW 083101774 A TW083101774 A TW 083101774A TW 83101774 A TW83101774 A TW 83101774A TW 282458 B TW282458 B TW 282458B
- Authority
- TW
- Taiwan
- Prior art keywords
- pct
- date
- sec
- pub
- r5nr4
- Prior art date
Links
- 102100022738 5-hydroxytryptamine receptor 1A Human genes 0.000 abstract 1
- 101710138638 5-hydroxytryptamine receptor 1A Proteins 0.000 abstract 1
- 239000002249 anxiolytic agent Substances 0.000 abstract 1
- 230000000949 anxiolytic effect Effects 0.000 abstract 1
- 229940005530 anxiolytics Drugs 0.000 abstract 1
- 239000011230 binding agent Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
- C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
- C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D319/20—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Quinoline Compounds (AREA)
- Pyrane Compounds (AREA)
- Indole Compounds (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB939304632A GB9304632D0 (en) | 1993-03-06 | 1993-03-06 | Amide derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW282458B true TW282458B (en:Method) | 1996-08-01 |
Family
ID=10731619
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW083101774A TW282458B (en:Method) | 1993-03-06 | 1994-03-01 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US5610295A (en:Method) |
| EP (1) | EP0687257B1 (en:Method) |
| JP (1) | JP3316214B2 (en:Method) |
| AT (1) | ATE154601T1 (en:Method) |
| AU (1) | AU6042094A (en:Method) |
| DE (1) | DE69403896T2 (en:Method) |
| DK (1) | DK0687257T3 (en:Method) |
| ES (1) | ES2102837T3 (en:Method) |
| GB (1) | GB9304632D0 (en:Method) |
| GR (1) | GR3024587T3 (en:Method) |
| PH (1) | PH31212A (en:Method) |
| TW (1) | TW282458B (en:Method) |
| WO (1) | WO1994020481A1 (en:Method) |
| ZA (1) | ZA941334B (en:Method) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5990114A (en) * | 1996-02-28 | 1999-11-23 | Recordati, S.A., Chemical And Pharmaceutical Company | Use of 5-HT1A receptor antagonists for the treatment of urinary incontinence |
| US20040058962A1 (en) * | 2002-06-14 | 2004-03-25 | Amedeo Leonardi | Phenylalkylamines and pyridylalkylamines |
| ITMI20021329A1 (it) * | 2002-06-14 | 2003-12-15 | Recordati Chem Pharm | Nuove ossialchilammine sostituite |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8907865D0 (en) * | 1989-04-07 | 1989-05-24 | Wyeth John & Brother Ltd | Tetrahydroquinoline derivatives |
| FR2660657B1 (fr) * | 1990-04-09 | 1993-05-07 | Adir | Nouveaux derives du 3-aminochromane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
| US5189179A (en) * | 1990-08-29 | 1993-02-23 | Merrell Dow Pharmaceuticals Inc. | Serotonin 5ht1a agonists |
| GB9022820D0 (en) * | 1990-10-19 | 1990-12-05 | Wyeth John & Brother Ltd | Piperazine derivatives |
-
1993
- 1993-03-06 GB GB939304632A patent/GB9304632D0/en active Pending
-
1994
- 1994-02-25 EP EP94906976A patent/EP0687257B1/en not_active Expired - Lifetime
- 1994-02-25 DK DK94906976.9T patent/DK0687257T3/da active
- 1994-02-25 WO PCT/GB1994/000372 patent/WO1994020481A1/en not_active Ceased
- 1994-02-25 AU AU60420/94A patent/AU6042094A/en not_active Abandoned
- 1994-02-25 ZA ZA941334A patent/ZA941334B/xx unknown
- 1994-02-25 ES ES94906976T patent/ES2102837T3/es not_active Expired - Lifetime
- 1994-02-25 US US08/436,410 patent/US5610295A/en not_active Expired - Lifetime
- 1994-02-25 JP JP51969494A patent/JP3316214B2/ja not_active Expired - Fee Related
- 1994-02-25 AT AT94906976T patent/ATE154601T1/de not_active IP Right Cessation
- 1994-02-25 DE DE69403896T patent/DE69403896T2/de not_active Expired - Fee Related
- 1994-03-01 TW TW083101774A patent/TW282458B/zh active
- 1994-03-04 PH PH47877A patent/PH31212A/en unknown
-
1997
- 1997-08-29 GR GR970402231T patent/GR3024587T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO1994020481A1 (en) | 1994-09-15 |
| JP3316214B2 (ja) | 2002-08-19 |
| GR3024587T3 (en) | 1997-12-31 |
| PH31212A (en) | 1998-05-05 |
| ZA941334B (en) | 1995-08-25 |
| DE69403896D1 (de) | 1997-07-24 |
| ATE154601T1 (de) | 1997-07-15 |
| AU6042094A (en) | 1994-09-26 |
| EP0687257B1 (en) | 1997-06-18 |
| EP0687257A1 (en) | 1995-12-20 |
| ES2102837T3 (es) | 1997-08-01 |
| JPH08507512A (ja) | 1996-08-13 |
| GB9304632D0 (en) | 1993-04-21 |
| DK0687257T3 (da) | 1997-08-18 |
| DE69403896T2 (de) | 1998-01-29 |
| US5610295A (en) | 1997-03-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB9300194D0 (en) | Piperazine derivatives | |
| CY2509B1 (en) | New thiazole derivatives with phosphodiesterase-inhibitting effect | |
| IL108258A0 (en) | Piperazine derivates, their preparation and pharmaceutical compositions containing them | |
| ZA949593B (en) | N-substituted azabicycloheptane derivatives their preparation and use | |
| ZA941739B (en) | Amide derivatives | |
| TW281673B (en:Method) | ||
| ES2094545T3 (es) | Derivados n-substituidos del 3-azabiciclo(3.2.0)heptano, como neurolepticos etc.. | |
| ZA938414B (en) | Substituted ortho-ethenylphenylacetic acid derivatives | |
| GB9304632D0 (en) | Amide derivatives | |
| GR3033358T3 (en) | NAPHTHAMIDE DERIVATIVES OF 3 -g(b)-AMINO AZABICYCLO OCTANE OR NONANE AS NEUROLEPTIC AGENTS | |
| NZ291855A (en) | Bridged azabicyclo-piperazin-1-yl-2-phenyl-butan-1-one derivatives as 5-ht1a antagonists | |
| PL314841A1 (en) | Derivatives of aminoalkyl aminopyridine | |
| ZA942971B (en) | Benzo(f)quinoxalinedione derivatives, their production and use in pharmaceutical agents. | |
| ZA939227B (en) | Novel triazoloquinazolines,their preparation and use | |
| MX9605143A (es) | Heterociclibenzonitrilos. | |
| MY115291A (en) | New substituted pyrazole derivatives, processes for their preparation nad their use as herbicides |